Across the recent three months, 12 analysts have shared their insights on Morgan Stanley MS, expressing a variety of opinions spanning from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 2 | 5 | 5 | 0 | 0 |
| Last 30D | 0 | 0 | 1 | 0 | 0 |
| 1M Ago | 2 | 1 | 1 | 0 | 0 |
| 2M Ago | 0 | 1 | 2 | 0 | 0 |
| 3M Ago | 0 | 3 | 1 | 0 | 0 |
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $95.01, along with a high estimate of $116.00 and a low estimate of $79.15. A decline of 3.34% from the prior average price target is evident in the current average.
Deciphering Analyst Ratings: An In-Depth Analysis
The standing of Morgan Stanley among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Saul Martinez | HSBC | Announces | Hold | $96.00 | - |
| Michael Carrier | B of A Securities | Raises | Buy | $100.00 | $95.00 |
| Jason Goldberg | Barclays | Raises | Overweight | $116.00 | $102.00 |
| Gerard Cassidy | RBC Capital | Maintains | Sector Perform | $85.00 | - |
| Richard Ramsden | Goldman Sachs | Raises | Buy | $100.00 | $89.00 |
| Andrew Lim | Societe Generale | Announces | Hold | $80.00 | - |
| Jeremy Sigee | Exane BNP Paribas | Announces | Neutral | $85.00 | - |
| Chris Kotowski | Oppenheimer | Raises | Outperform | $103.00 | $98.00 |
| Dick Bove | Odeon Capital | Announces | Hold | $79.15 | - |
| Glenn Schorr | Evercore ISI Group | Lowers | Outperform | $97.00 | $102.00 |
| James Fotheringham | BMO Capital | Lowers | Outperform | $101.00 | $102.00 |
| Chris Kotowski | Oppenheimer | Lowers | Outperform | $98.00 | $100.00 |
Key Insights:
- Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Morgan Stanley. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Morgan Stanley compared to the broader market.
- Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Morgan Stanley's stock. This comparison reveals trends in analysts' expectations over time.
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Morgan Stanley's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
Stay up to date on Morgan Stanley analyst ratings.
All You Need to Know About Morgan Stanley
Morgan Stanley is a global investment bank whose history, through its legacy firms, can be traced back to 1924. The company has institutional securities, wealth management, and investment management segments. The company had over $4 trillion of client assets as well as over 80,000 employees at the end of 2022. Approximately 50% of the company's net revenue is from its institutional securities business, with the remainder coming from wealth and investment management. The company derives about 30% of its total revenue outside the Americas.
Morgan Stanley's Financial Performance
Market Capitalization Analysis: With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.
Revenue Growth: Morgan Stanley displayed positive results in 3 months. As of 30 September, 2023, the company achieved a solid revenue growth rate of approximately 2.3%. This indicates a notable increase in the company's top-line earnings. When compared to others in the Financials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Morgan Stanley's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 18.22%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Morgan Stanley's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 2.48% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Morgan Stanley's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 0.19%, the company may face hurdles in achieving optimal financial performance.
Debt Management: With a high debt-to-equity ratio of 2.84, Morgan Stanley faces challenges in effectively managing its debt levels, indicating potential financial strain.
The Core of Analyst Ratings: What Every Investor Should Know
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
